» Articles » PMID: 37701356

Prevalence and Determinants of Resistant Hypertension in the Delta Region of Egypt: A Prospective Observational Study

Overview
Journal Health Sci Rep
Specialty General Medicine
Date 2023 Sep 13
PMID 37701356
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Aims: Hypertension (HTN) is a leading cause of morbidity and mortality affecting about 30%-40% of the adult population in developed countries. Fewer data were published about the prevalence, sociodemographics, and clinical characteristics of the resistant hypertensive population in Egypt. Hence, our aim is to focus the attention on these determinants especially in the delta region of Egypt.

Methods: Data belonging to patients visiting our HTN clinic in the Cardiovascular Department, Tanta University Hospital, Gharbeyah Governorate, Egypt, were collected over 12 months, between January 1, 2022, and 31 December 31, 2022, and then carefully analyzed.

Results: We found that the prevalence of resistant hypertension (RHTN) in the delta region of Egypt was 18%. We noted more RHTN cases in older age, that is, mean ± Std. was 51.5 ± 13.24 and 62.1 ± 7.56 for non-RHTN and RHTN, respectively. Also, the prevalence was higher in women representing about 54.4% of cases. Sixty-two percent of the patients with RH were obese (mean ± Std. of body mass index was 30.7 ± 5.36 in HTN and 47.7 ± 30.3 in RHTN groups with value <0.001). We found a significant relationship between chronic kidney disease, diabetes, and RHTN.

Conclusion: Control of HTN among the Egyptian population in the delta region was unsatisfactory and higher than rates published globally. RH was more obvious in women, elderly, obese population, and diabetic and chronic kidney disease patients. Excessive use of nonsteroidal anti-inflammatory drugs, smoking, and high salt intake were clearly observed.

Citing Articles

Psychological stress among hypertensive male patients in Jordan: prevalence and associated factors.

Aldirawi A, Alhalaiqa F, Alwawi A, Abuzerr S BMC Public Health. 2024; 24(1):3508.

PMID: 39695470 PMC: 11657353. DOI: 10.1186/s12889-024-20733-0.


Prevalence and determinants of resistant hypertension in the delta region of Egypt: A prospective observational study.

Elbarbary M, Shoeib O, El-Saied S, Atlm R, Alkassas A Health Sci Rep. 2023; 6(9):e1441.

PMID: 37701356 PMC: 10494290. DOI: 10.1002/hsr2.1441.

References
1.
Cushman W, Whelton P, Fine L, Wright Jr J, Reboussin D, Johnson K . SPRINT Trial Results: Latest News in Hypertension Management. Hypertension. 2015; 67(2):263-5. PMC: 4768735. DOI: 10.1161/HYPERTENSIONAHA.115.06722. View

2.
Pimenta E, Oparil S . Management of hypertension in the elderly. Nat Rev Cardiol. 2012; 9(5):286-96. DOI: 10.1038/nrcardio.2012.27. View

3.
Carey R, Calhoun D, Bakris G, Brook R, Daugherty S, Dennison-Himmelfarb C . Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association. Hypertension. 2018; 72(5):e53-e90. PMC: 6530990. DOI: 10.1161/HYP.0000000000000084. View

4.
Gijon-Conde T, Graciani A, Banegas J . Resistant hypertension: demography and clinical characteristics in 6,292 patients in a primary health care setting. Rev Esp Cardiol (Engl Ed). 2014; 67(4):270-6. DOI: 10.1016/j.rec.2013.09.027. View

5.
Marquez P, Torres O, San-Jose A, Vidal X, Agusti A, Formiga F . Potentially Inappropriate Antihypertensive Prescriptions to Elderly Patients: Results of a Prospective, Observational Study. Drugs Aging. 2017; 34(6):453-466. DOI: 10.1007/s40266-017-0452-z. View